19.1 |
Sera and Immunoglobulins |
|
C |
Anti-D(Rho) Immunoglobulin |
Injection 0.25 mg/mL in set of 5 mL |
C |
Anti-rabies Immunoglobulin |
Injection 1000 IU/5 mL ampoule |
B |
Snake venom polyvalent antiserum |
Injection in vial |
B |
Tetanus Immunoglobulin (human) |
Injection 50,000 IU in vial |
19.2 |
Vaccines |
|
19.2.1 |
For Immunisation |
|
A |
BCG Vaccine (Bacillus Calmette Guerin) |
Injection 20 doses in 10 mL vial |
A |
DPT Vaccine (Diphtheria-Pertussis-Tetanus) |
Injection 20 doses in 10 mL vial |
A |
Measles Vaccine (live attenuated) |
Injection 10 doses in vial |
A |
Poliomyelitis Vaccine (live attenuated) |
Oral solution 20 doses in container |
A |
Tetanus (toxoid) Vaccine |
Injection 20 doses in 10 mL vial |
19.2.2 |
For specific group of individuals |
|
D |
Cholera Vaccine |
Injection 10 doses in 5 mL vial |
D |
Human Diploid Cell Rabies |
Vaccine Injection |
D |
Rubella Vaccine (live attenuated) |
Injection 10 doses in 5 mL vial |
D |
Yellow Fever Vaccine |
Injection 10 doses in vial (with diluent) |